Everolimus is approved to treat breast cancer, pancreatic cancer, and renal cell carcinoma. It is also being studied in the treatment of other types of cancers, including multiple myeloma.
SparkCures ID | 56 |
---|---|
Developed By | Novartis |
Generic Name | Everolimus |
Additional Names | Afinitor, RAD001 |
Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.